Search Page

1

Cite

Risk of drug-induced liver injury in chronic hepatitis C and tuberculosis co- infection: a systematic review and meta- analysis.

Wei X, Cai R, Wu X, Su Y, Lian S, Nan T, Ye X, Wei J. Wei X, et al. BMC Infect Dis. 2025 Nov 13;25(1):1566. doi: 10.1186/s12879-025-12005-y. BMC Infect Dis. 2025. PMID: 41233746 Free article.

Cite

2

Cite

Ubiquitin E3 Ligases and p53 in Doxorubicin-Induced Cardiotoxicity.

Tachibana S, Otaki Y, Goto J, Watanabe T, Watanabe M. Tachibana S, et al. Int J Mol Sci. 2025 Oct 22;26(21):10252. doi: 10.3390/ijms262110252. Int J Mol Sci. 2025. PMID: 41226293 Free PMC article. Review.

Cite

3

Cite

Chemobrain and Cancer Survivorship: A Scoping Review of the Literature.

Rovito MJ, Chauhan KM, Baig H. Rovito MJ, et al. Cancer Med. 2025 Nov;14(21):e71383. doi: 10.1002/cam4.71383. Cancer Med. 2025. PMID: 41223143 Free PMC article. Review.

Cite

4

Cite

Otoprotective measures for cisplatin-based chemoradiotherapy-induced toxicity in patients with head and neck cancer: a systematic review and meta-analysis.

Marchetti KR, Guerra LD, Gondim PAL, de Castro Junior G. Marchetti KR, et al. Support Care Cancer. 2025 Nov 10;33(12):1034. doi: 10.1007/s00520-025-10103-w. Support Care Cancer. 2025. PMID: 41212257 Review.

Cite

5

Cite

Cardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in ERBB2-Positive Advanced Breast Cancer: A Systematic Review and Meta-Analysis.

Seth L, Bhave A, Kollapaneni S, Shah V, Nahle T, Blaes A, Dent S, Hurvitz SA, Guha A. Seth L, et al. JAMA Netw Open. 2025 Nov 3;8(11):e2540336. doi: 10.1001/jamanetworkopen.2025.40336. JAMA Netw Open. 2025. PMID: 41206886 Free PMC article.

Cite

6

Cite

State-of-the-Art Review: Antibiotic Allergy-A Multidisciplinary Approach to Delabeling.

Mitri EA, Reynolds GK, Copaescu AM, Cox F, Waldron JL, Peter JG, Trubiano JA. Mitri EA, et al. Clin Infect Dis. 2025 Nov 6;81(4):e74-e92. doi: 10.1093/cid/ciaf401. Clin Infect Dis. 2025. PMID: 41206553 Review.

Cite

7

Cite

"Electrocardiographic and Echocardiographic Monitoring for Early Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis".

Sheth PD, Srinath C, Mayagondanahallay Chandrashekaraiah P, Madhukar RW, Mahadevappa M. Sheth PD, et al. Echocardiography. 2025 Nov;42(11):e70331. doi: 10.1111/echo.70331. Echocardiography. 2025. PMID: 41205158 Review.

Cite

8

Cite

Toxic heavy metal exposure and heart health: a systematic review and meta-analysis of 324,331 patients.

Cheema S, Hussain SI, Faheem MSB, Jalal AA, Rifai M, Dar A, Burhan M, Shahid A, Ali MS, Anwar A, Khalid M, Samadi S. Cheema S, et al. BMC Cardiovasc Disord. 2025 Nov 7;25(1):792. doi: 10.1186/s12872-025-05248-9. BMC Cardiovasc Disord. 2025. PMID: 41204397 Free PMC article.

Cite

9

Cite

Influence of genetic polymorphisms on gefitinib pharmacokinetics and adverse drug reactions in non-small cell lung cancer patients.

Shenoy PV, Baburaj G, Damerla RR, Pai A, Mailankody S, Munisamy M, Mallayasamy S, Udupa KS, Kolesar J, Rao M. Shenoy PV, et al. Cancer Metastasis Rev. 2025 Nov 6;44(4):82. doi: 10.1007/s10555-025-10299-7. Cancer Metastasis Rev. 2025. PMID: 41199076 Free PMC article. Review.

Cite

10

Cite

Stevens-Johnson syndrome or toxic epidermal necrolysis from antihypertensive medications: A systematic review of cases.

Gibons RM, Behers BJ, Sanchez C, Melchor J, Riveros N, Moretta LF, Bentze NG. Gibons RM, et al. Medicine (Baltimore). 2025 Oct 17;104(42):e45350. doi: 10.1097/MD.0000000000045350. Medicine (Baltimore). 2025. PMID: 41189166 Free PMC article. Review.

Cite

11

Cite

Incorporation of target safety review in drug discovery.

Amano Y, Jeffy B, Anayama H, Goodwin J. Amano Y, et al. J Toxicol Sci. 2025;50(11):593-599. doi: 10.2131/jts.50.593. J Toxicol Sci. 2025. PMID: 41183896 Free article. Review.

Cite

12

Cite

Reactogenicity, safety, and immunogenicity of a quadrivalent seasonal influenza vaccine in adults aged 65 years and older: Phase 4 study results from India during December 2023-February 2024.

Jain V, Cauwberghs F, Qian H, Best-Sule K, Gupta V, Tatchou EN, Struyf F. Jain V, et al. Hum Vaccin Immunother. 2025 Dec;21(1):2578084. doi: 10.1080/21645515.2025.2578084. Epub 2025 Oct 29. Hum Vaccin Immunother. 2025. PMID: 41159757 Free PMC article. Clinical Trial.

Cite

13

Cite

Drug Repositioning in Doxorubicin-Induced Cardiotoxicity Protection.

Kosić M, Pajović V, Jovanović M, Japundžić-Žigon N. Kosić M, et al. Int J Mol Sci. 2025 Oct 17;26(20):10130. doi: 10.3390/ijms262010130. Int J Mol Sci. 2025. PMID: 41155422 Free PMC article. Review.

Cite

14

Cite

miR-106b-5p as a Central Regulator of Cancer Progression and Chemotherapy-Induced Cardiotoxicity: From Molecular Mechanisms to Clinical Translation.

Asensio Lopez MDC, Ruiz Ballester M, Bastida Nicolas FJ, Soler Pardo F, Alonso-Romero JL, Caro-Martinez C, Pascual Figal D, Lax A. Asensio Lopez MDC, et al. Int J Mol Sci. 2025 Oct 14;26(20):10002. doi: 10.3390/ijms262010002. Int J Mol Sci. 2025. PMID: 41155295 Free PMC article. Review.

Cite

15

Cite

Jellyfish Venom-Induced Cardiotoxicity and Immune Responses: Mechanisms and Potential Therapeutic Strategies.

Li Y, Qiu Z, Li B, Geng X, Yu X, Li Y, Li W, Yang J. Li Y, et al. Mar Drugs. 2025 Sep 23;23(10):369. doi: 10.3390/md23100369. Mar Drugs. 2025. PMID: 41149572 Free PMC article. Review.

Cite

16

Cite

Management of adverse reactions to targeted therapy and immunotherapy for pancreatic cancer: A literature review.

Huang F, Huang ZP. Huang F, et al. J Int Med Res. 2025 Oct;53(10):3000605251388257. doi: 10.1177/03000605251388257. Epub 2025 Oct 27. J Int Med Res. 2025. PMID: 41145442 Free PMC article. Review.

Cite

17

Cite

Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives.

Arendt N, Kopsida M, Lennernäs H, Sjöblom M, Heindryckx F. Arendt N, et al. Eur J Pharmacol. 2025 Nov 15;1007:178282. doi: 10.1016/j.ejphar.2025.178282. Epub 2025 Oct 23. Eur J Pharmacol. 2025. PMID: 41138833 Free article. Review.

Cite

18

Cite

Guidelines From the French-Speaking Society for Histocompatibility and Immunogenetics (SFHI) for Harmonisation of HLA Genotyping in Autoimmune Diseases, Drug Hypersensitivity and Pharmacogenetics.

Renac V, Moalic V, Dautin G, Cherel M, Mercier B, Walencik A, Cohen J, Farce F, Proust B, Kaveri R, Humeau C, Picard C, Pedron B, Dubois V, Taupin JL, Elsermans V, Top-Raymond I, Ferrari-Lacraz S, Barocas A, Masson D, Essaydi A, Guidicelli G, Ralazamahaleo M, Congy-Jolivet N. Renac V, et al. HLA. 2025 Oct;106(4):e70442. doi: 10.1111/tan.70442. HLA. 2025. PMID: 41137743 Review.

Cite

19

Cite

Modifying Hy's Law and eDISH for the modern idiosyncratic DILI era.

Cohen EB, Lewis JH. Cohen EB, et al. Expert Opin Drug Metab Toxicol. 2025 Oct;21(10):1159-1168. doi: 10.1080/17425255.2025.2577677. Epub 2025 Nov 4. Expert Opin Drug Metab Toxicol. 2025. PMID: 41137205 Review.

Cite

20

Cite

Using the Electronic Health Record to Facilitate Drug Allergy Delabeling.

Molloy MJ, Yan AP, Wilson AE, Beus J, Hess LM. Molloy MJ, et al. Curr Allergy Asthma Rep. 2025 Oct 25;25(1):49. doi: 10.1007/s11882-025-01229-2. Curr Allergy Asthma Rep. 2025. PMID: 41136878 Free PMC article. Review.

Cite

21

Cite

Echocardiographic monitoring in cancer therapy: clinical guidance for cardiologists and oncologists.

Sperlongano S, Verde G, Guarnaccia N, Gragnano F, Benfari G, De Sio V, Ilardi F, Lisi M, Malagoli A, Mandoli GE, Pastore MC, Santoro C, Cameli M, Cimmino G, Calabrò P, D'Andrea A. Sperlongano S, et al. Heart Fail Rev. 2025 Dec;30(6):1591-1602. doi: 10.1007/s10741-025-10569-0. Epub 2025 Oct 24. Heart Fail Rev. 2025. PMID: 41134513 Review.

Cite

22

Cite

Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials.

Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart M. Gresham G, et al. Cancer. 2025 Oct 15;131 Suppl 2:e70086. doi: 10.1002/cncr.70086. Cancer. 2025. PMID: 41123586 Review.

Cite

23

Cite

Methods for implementing and reporting the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient-reported adverse events in cancer clinical trials.

Dueck AC, Thanarajasingam G, Rogak L, Mazza GL, Langlais BT, Noble BN, Ginos BF, Mead-Harvey C, Yee CI, Lee MK, Deal AM, Meek EA, Basch E. Dueck AC, et al. Cancer. 2025 Oct 15;131 Suppl 2(Suppl 2):e35951. doi: 10.1002/cncr.35951. Cancer. 2025. PMID: 41123546 Free PMC article. Review.

Cite

24

Cite

Measuring the multidimensional aspects of tolerability.

Mitchell SA, Altshuler RD, St Germain DC, Streck BP, Chen AP, Minasian LM. Mitchell SA, et al. Cancer. 2025 Oct 15;131 Suppl 2(Suppl 2):e70085. doi: 10.1002/cncr.70085. Cancer. 2025. PMID: 41123478 Free PMC article. Review.

Cite

25

Cite

[Drug Excipients. Necessary, but not Harmless].

López Alarcón MD, Justo Hernández A, Santos Cruz P. López Alarcón MD, et al. Farm Comunitarios. 2025 Oct 1;17(4):65-80. doi: 10.33620/FC.2173-9218.(2025).30. eCollection 2025 Oct 15. Farm Comunitarios. 2025. PMID: 41122218 Free PMC article. Review. Spanish.

Cite

26

Cite

Polypharmacy Intervention Studies in Older Adults: Challenges in Proving Benefits in Hard Clinical Outcomes.

Isop LM, Neculau AE, Kramers CK, Dima L. Isop LM, et al. Am J Ther. 2025 Sep-Oct 01;32(5):e458-e466. doi: 10.1097/MJT.0000000000002010. Am J Ther. 2025. PMID: 41099738 Review.

Cite

27

Cite

Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity.

Teschke R. Teschke R. Int J Mol Sci. 2025 Sep 30;26(19):9574. doi: 10.3390/ijms26199574. Int J Mol Sci. 2025. PMID: 41096839 Free PMC article. Review.

Cite

28

Cite

A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus.

van Vollenhoven RF, Wang L, Merrill JT, Liu Y, Bao C, Li F, Hu J, Huang C, Zhao J, Huang C, Mo H, Wei W, Lu F, Li J, Zhao D, Wang W, Li L, Zuraw Q, Wang X, Wang X, Fang J, Zhang F; 18C010 Trial Investigators. van Vollenhoven RF, et al. N Engl J Med. 2025 Oct 16;393(15):1475-1485. doi: 10.1056/NEJMoa2414719. N Engl J Med. 2025. PMID: 41092329 Clinical Trial.

Cite

29

Cite

[Research progress on population load and hepatotoxicity of glyphosate].

Lu J, Wang BS, Zhu BL. Lu J, et al. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2025 Sep 20;43(9):713-720. doi: 10.3760/cma.j.cn121094-20240422-00174. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2025. PMID: 41073347 Review. Chinese.

Cite

30

Cite

Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction.

Zhang J, Li H, Zhang Y, Huang J, Ren L, Zhang C, Zou Q, Zhang Y. Zhang J, et al. Brief Bioinform. 2025 Aug 31;26(5):bbaf533. doi: 10.1093/bib/bbaf533. Brief Bioinform. 2025. PMID: 41052279 Free PMC article. Review.

Cite

31

Cite

Comparative effectiveness and safety of vancomycin versus linezolid for the treatment of central nervous system infections: a meta-analysis.

Zhou L, Yao Q, Wang Z, Yu L, Yu Z, Zhao Y. Zhou L, et al. Front Cell Infect Microbiol. 2025 Sep 18;15:1668983. doi: 10.3389/fcimb.2025.1668983. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 41050758 Free PMC article. Review.

Cite

32

Cite

Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients.

Gomaa NF, Werida RH, El-Gowily AG, El-Bassiouny NA. Gomaa NF, et al. Support Care Cancer. 2025 Oct 1;33(10):897. doi: 10.1007/s00520-025-09947-z. Support Care Cancer. 2025. PMID: 41034674 Free PMC article. Clinical Trial.

Cite

33

Cite

[Prediction of Severe Skin Disorders Induced by Anti-epidermal Growth Factor Receptor Antibody Drugs].

Takahashi H. Takahashi H. Yakugaku Zasshi. 2025;145(10):801-807. doi: 10.1248/yakushi.25-00092. Yakugaku Zasshi. 2025. PMID: 41034104 Free article. Review. Japanese.

Cite

34

Cite

[Cutaneous reactions to drugs].

Lederbogen I, Meier-Schiesser B. Lederbogen I, et al. Ther Umsch. 2025 Sep;82(4):111-116. doi: 10.23785/TU.2025.04.003. Ther Umsch. 2025. PMID: 41031693 Review. German.

Cite

35

Cite

Adverse Events Following Short-Course Systemic Corticosteroids Among Children and Adolescents: A Systematic Review and Meta-Analysis.

Lima JP, Chowdhury SR, Tangamornsuksan W, Zhai C, Chu X, Matos Silva J, Kabir H, Chowdhury MR, Couban R, Walsh M, Rochwerg B, Eltorki M, Guyatt GH, Chu D. Lima JP, et al. JAMA Netw Open. 2025 Sep 2;8(9):e2534953. doi: 10.1001/jamanetworkopen.2025.34953. JAMA Netw Open. 2025. PMID: 41026484 Free PMC article.

Cite

36

Cite

Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions.

Ngcobo NN. Ngcobo NN. J Eval Clin Pract. 2025 Oct;31(7):e70283. doi: 10.1111/jep.70283. J Eval Clin Pract. 2025. PMID: 41025835 Free PMC article. Review.

Cite

37

Cite

Association of HLA-B*53 With DRESS Syndrome in Patients Treated With Raltegravir: Two Case Reports and a Literature Review.

Ramos-Del Moral C, Rodríguez Cortés P, Navares-Gómez M, Campodónico D, Almenara de Riquer S, Barrios Blandino A, Mejía-Abril G, Gómez-Fernández A, Romero Sastre O, Carles García P, Abad-Santos F. Ramos-Del Moral C, et al. Basic Clin Pharmacol Toxicol. 2025 Nov;137(5):e70118. doi: 10.1111/bcpt.70118. Basic Clin Pharmacol Toxicol. 2025. PMID: 41025677 Free PMC article. Review.

Cite

38

Cite

Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper.

Leonardi A, Bozkurt B, Silva D, Mortz CG, Baudouin C, Atanaskovic-Markovic M, Sharma V, Doan S, Agarwal S, Pérez-Formigo D, Vasconcelos MJ, Baudouin FB, Chorzepa G, Fauquert JL, Calder V, Demoly P, Delgado L. Leonardi A, et al. Allergy. 2025 Nov;80(11):2953-2972. doi: 10.1111/all.70074. Epub 2025 Sep 30. Allergy. 2025. PMID: 41025570 Free PMC article. Review.

Cite

39

Cite

Acute and reversible dyskinesias secondary to lithium toxicity: case report and literature review.

Falletti M, Di Flumeri F, Zampogna A, Patera M, Fabbrini G, Suppa A. Falletti M, et al. BMC Neurol. 2025 Sep 29;25(1):393. doi: 10.1186/s12883-025-04419-7. BMC Neurol. 2025. PMID: 41023702 Free PMC article. Review.

Cite

40

Cite

Hepatotoxicity of Nanoparticle-Based Anti-Cancer Drugs: Insights into Toxicity and Mitigation Strategies.

Skorzynski M, Krol M, Braniewska A. Skorzynski M, et al. Int J Nanomedicine. 2025 Sep 23;20:11697-11715. doi: 10.2147/IJN.S543433. eCollection 2025. Int J Nanomedicine. 2025. PMID: 41019236 Free PMC article. Review.

Cite

41

Cite

Clinical, pathological and immunological features of toxic-epidermal necrolysis like lupus erythematosus: A systematic review and proposal for diagnostic criteria.

Subhadarshani S, Griffith T, Thornton Z, Nicholas A. Subhadarshani S, et al. Lupus. 2025 Oct;34(12):1221-1229. doi: 10.1177/09612033251371801. Epub 2025 Aug 26. Lupus. 2025. PMID: 41017023 Free PMC article.

Cite

42

Cite

Integrating exercise and medication management in geriatric care: a holistic strategy to enhance health outcomes and reduce polypharmacy.

Izquierdo M, Ramírez-Vélez R, Fiatarone Singh MA. Izquierdo M, et al. Lancet Healthy Longev. 2025 Sep;6(9):100763. doi: 10.1016/j.lanhl.2025.100763. Epub 2025 Sep 25. Lancet Healthy Longev. 2025. PMID: 41015054 Free article. Review.

Cite

43

Cite

Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity.

Meshrkey F, Ibrahim SY, Bagchi RA, Richardson WJ. Meshrkey F, et al. Cells. 2025 Sep 20;14(18):1471. doi: 10.3390/cells14181471. Cells. 2025. PMID: 41002436 Free PMC article. Review.

Cite

44

Cite

A systematic mapping review on the capability of large language models in drug-drug interaction analysis.

Mondal H, Dash I, Mondal S, Varikasuvu SR, Gayen RK, Sharma S, Biri SK. Mondal H, et al. Expert Rev Clin Pharmacol. 2025 Sep;18(9):683-690. doi: 10.1080/17512433.2025.2568090. Epub 2025 Sep 29. Expert Rev Clin Pharmacol. 2025. PMID: 40999995 Review.

Cite

45

Cite

Adverse Effects and Drug Reactions in Equids.

Wilson KE, Davis JL. Wilson KE, et al. Vet Clin North Am Equine Pract. 2025 Dec;41(3):653-674. doi: 10.1016/j.cveq.2025.08.011. Epub 2025 Sep 24. Vet Clin North Am Equine Pract. 2025. PMID: 40998644 Review.

Cite

46

Cite

Cardiac imaging in oncology: the detection of cardiotoxicity.

Negishi T, Miyazaki S, Park J, Negishi K. Negishi T, et al. Heart. 2025 Oct 29;111(22):1057-1066. doi: 10.1136/heartjnl-2024-323864. Heart. 2025. PMID: 40998519 Review.

Cite

47

Cite

Cognitive dysfunction in chemobrain: Molecular mechanisms and therapeutic implications.

Kim HG, Rashid MA, Poleschuk M, Ullah F, Lee SH, Kim SH, Qin B, Zheng XFS, Jang MH. Kim HG, et al. Biomed Pharmacother. 2025 Nov;192:118581. doi: 10.1016/j.biopha.2025.118581. Epub 2025 Sep 24. Biomed Pharmacother. 2025. PMID: 40997625 Free article. Review.

Cite

48

Cite

Risk prediction models for cancer therapy related cardiac dysfunction in patients with cancer and cancer survivors: systematic review and meta-analysis.

Gomes C, Geels J, Debray TPA, Malekzadeh A, Asselbergs FW, Linschoten M. Gomes C, et al. BMJ. 2025 Sep 23;390:e084062. doi: 10.1136/bmj-2025-084062. BMJ. 2025. PMID: 40987514 Free PMC article.

Cite

49

Cite

Advancements in the diagnosis and management of capecitabine-induced hand-foot syndrome.

Chen B, Wang X, Meng L. Chen B, et al. J Cancer Res Clin Oncol. 2025 Sep 22;151(10):265. doi: 10.1007/s00432-025-06319-2. J Cancer Res Clin Oncol. 2025. PMID: 40976784 Free PMC article. Review.

Cite

50

Cite

Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial.

Kiguba R, Ndagije HB, Mwebaza N, Ssenyonga R, Giibwa L, Isabirye G, Owiny J, Nambasa V, Ntale I, Atuhaire J, Mwesigwa D, Mayengo J, Walusimbi D, Mugisa I, Katureebe C, Harrison K, Karamagi C, Pirmohamed M. Kiguba R, et al. Lancet Glob Health. 2025 Oct;13(10):e1761-e1770. doi: 10.1016/S2214-109X(25)00299-2. Lancet Glob Health. 2025. PMID: 40975083 Free PMC article. Clinical Trial.

Cite

51

Cite

Effect of Cardioprotection on the Right Ventricular Function in Breast Cancer Patients Receiving Potentially Cardiotoxic Therapy: A SAFE Trial Substudy.

Del Bene MR, Meattini I, Pilato G, Becherini C, Martella F, Salvestrini V, Marrazzo L, Saieva C, Olivotto I, Barletta G, Livi L. Del Bene MR, et al. Echocardiography. 2025 Sep;42(9):e70291. doi: 10.1111/echo.70291. Echocardiography. 2025. PMID: 40965835 Free PMC article. Clinical Trial.

Cite

52

Cite

[Hepatitis diagnostics : Differential diagnosis of viral hepatitis from other causes of elevated transaminases].

Straub BK, Labenz C, Weber A, Drebber U. Straub BK, et al. Pathologie (Heidelb). 2025 Nov;46(6):400-412. doi: 10.1007/s00292-025-01472-4. Epub 2025 Sep 18. Pathologie (Heidelb). 2025. PMID: 40965633 Review. German.

Cite

53

Cite

Secukinumab-induced erythema multiforme-like drug eruption in generalized pustular psoriasis: a case report and literature review.

Sun J, Wang Z, Xu Z. Sun J, et al. Eur J Dermatol. 2025 Aug 1;35(4):279-284. doi: 10.1684/ejd.2025.4922. Eur J Dermatol. 2025. PMID: 40965524 Review.

Cite

54

Cite

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.

López-Pascual E, Moreno-Torres M, Moro E, Rapisarda A, Ortega-Vallbona R, Serrano-Candelas E, Gozalbes R, Jover R, Castell JV. López-Pascual E, et al. Arch Toxicol. 2025 Dec;99(12):5075-5091. doi: 10.1007/s00204-025-04178-x. Epub 2025 Sep 16. Arch Toxicol. 2025. PMID: 40958018 Free PMC article. Review.

Cite

55

Cite

Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12-59 months.

Schnyder Ghamloush S, Fanning S, Essink B, Eder F, Snape MD, Stoszek SK, Guo R, Dhar R, Righi V, Morsy L, Kapoor A, El Asmar L, Shaw CA. Schnyder Ghamloush S, et al. Hum Vaccin Immunother. 2025 Dec;21(1):2557676. doi: 10.1080/21645515.2025.2557676. Epub 2025 Sep 15. Hum Vaccin Immunother. 2025. PMID: 40953212 Free PMC article. Clinical Trial.

Cite

56

Cite

The Development and Use of Office of New Drugs Custom Medical Queries for Safety Analyses of Clinical Trial Data.

Proestel S, Popat V, Unger EF, Jeng LJB. Proestel S, et al. Drug Saf. 2025 Dec;48(12):1331-1337. doi: 10.1007/s40264-025-01582-1. Epub 2025 Sep 15. Drug Saf. 2025. PMID: 40952627 Free PMC article. Review.

Cite

57

Cite

Adverse effects of Janus kinase inhibitors with relevance for daily practice in dermatology.

Rajput Khokhar A, Ghoreschi K, Huynh J. Rajput Khokhar A, et al. J Dtsch Dermatol Ges. 2025 Sep;23(9):1127-1140. doi: 10.1111/ddg.15796. J Dtsch Dermatol Ges. 2025. PMID: 40952332 Free PMC article. Review.

Cite

58

Cite

Safety, pharmacokinetics, and bioequivalence of vunakizumab injection, a specific dermatitis drug, in healthy Chinese volunteers: an open-label, randomized, two-stage, two-sequence cross-over study.

Dong Y, Gao X, Feng S, Lin L, Shen K, Hu W. Dong Y, et al. Expert Opin Drug Metab Toxicol. 2025 Sep;21(9):1117-1123. doi: 10.1080/17425255.2025.2558829. Epub 2025 Sep 15. Expert Opin Drug Metab Toxicol. 2025. PMID: 40947125 Clinical Trial.

Cite

59

Cite

Protective Role of Key Micronutrients in Chemotherapy-Induced Organ Toxicity: A Comprehensive Review of Mechanistic Insights and Clinical Implications.

Konstantinidis I, Tsokkou S, Gavriilaki E, Delis G, Papamitsou T. Konstantinidis I, et al. Nutrients. 2025 Aug 31;17(17):2838. doi: 10.3390/nu17172838. Nutrients. 2025. PMID: 40944226 Free PMC article. Review.

Cite

60

Cite

Potential connections between senescence and chemobrain: An early overview of literature.

Melhem N, Qutifan S, Alsalem M, Saleh T. Melhem N, et al. Ageing Res Rev. 2025 Dec;112:102896. doi: 10.1016/j.arr.2025.102896. Epub 2025 Sep 10. Ageing Res Rev. 2025. PMID: 40939683 Review.

Cite

61

Cite

Concomitant use of antidepressants and classic psychedelics: A scoping review.

Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen J, Schoevers R. Tap SC, et al. J Psychopharmacol. 2025 Oct;39(10):1072-1088. doi: 10.1177/02698811251368360. Epub 2025 Sep 12. J Psychopharmacol. 2025. PMID: 40937732 Free PMC article. Review.

Cite

62

Cite

Evaluating the use of rodents as in vitro, in vivo and ex vivo experimental models for the assessment of tyrosine kinase inhibitor-induced cardiotoxicity: a systematic review.

Gill L, Chadwick A, Meeson AP, Barrett-Jolley R, Phelan MM, Oldershaw RA. Gill L, et al. Arch Toxicol. 2025 Dec;99(12):4801-4828. doi: 10.1007/s00204-025-04159-0. Epub 2025 Sep 11. Arch Toxicol. 2025. PMID: 40935867 Free PMC article. Review.

Cite

63

Cite

Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial.

Xia Y, Zhu Y, Ling L, Xu F, Yang Y, Ye J, Tan W, Chen Z, Liu Q, Wei W, Zhang J, Zhang A, Zhang L, Song E, Gong C. Xia Y, et al. BMJ. 2025 Sep 11;390:e084290. doi: 10.1136/bmj-2025-084290. BMJ. 2025. PMID: 40935571 Free PMC article. Clinical Trial.

Cite

64

Cite

Diagnosis of Quinolone Hypersensitivity: An EAACI Position Paper.

Gelincik A, Brockow K, Çelik GE, Demir S, Doña Diaz I, Ebo DG, Mayorga C, Labella M, Sabato V, Jaén MJT. Gelincik A, et al. Allergy. 2025 Nov;80(11):2988-3011. doi: 10.1111/all.70037. Epub 2025 Sep 10. Allergy. 2025. PMID: 40931617 Review.

Cite

65

Cite

Evolving Cardioprotective Strategies in Cardio-Oncology: A Narrative Review.

Wadden E, Chandrasekhar S, Jordan T, Diaz A, Alhama-Belotto M, Andrikopoulou E, Leedy D, Vasbinder A, Cheng RK. Wadden E, et al. Curr Cardiol Rep. 2025 Sep 9;27(1):131. doi: 10.1007/s11886-025-02283-y. Curr Cardiol Rep. 2025. PMID: 40924255 Review.

Cite

66

Cite

Natural Products From Traditional Chinese Medicine: Potential Therapeutic Agents in Cancer Therapy-Induced Cardiotoxicity.

Jin R, You Q, Li C, Zhao N, Jia C, Koo C, Zhang W, Liu B, Huang K. Jin R, et al. Drug Des Devel Ther. 2025 Sep 3;19:7653-7680. doi: 10.2147/DDDT.S545216. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40923004 Free PMC article. Review.

Cite

67

Cite

Applications of Federated Large Language Model for Adverse Drug Reactions Prediction: Scoping Review.

Guo D, Choo KR. Guo D, et al. J Med Internet Res. 2025 Sep 8;27:e68291. doi: 10.2196/68291. J Med Internet Res. 2025. PMID: 40921101 Free PMC article. Review.

Cite

68

Cite

Lazertinib: A Cardio-Safer Alternative to Osimertinib for Epidermal Growth Factor Receptor L858R/T790M Double-Mutant Tyrosine Kinase Resistant Non-Small Cell Lung Cancer.

Gawli CS, Nagpure NR, Patil BR, Ochi N, Takigawa N, Patel HM. Gawli CS, et al. Drug Dev Res. 2025 Sep;86(6):e70153. doi: 10.1002/ddr.70153. Drug Dev Res. 2025. PMID: 40919674 Review.

Cite

69

Cite

HER2-targeted therapies and cardiotoxicity: From major concern to manageable risk.

Pamungkas RP, Pratiwi L, Sutanto H. Pamungkas RP, et al. Curr Probl Cardiol. 2025 Nov;50(11):103168. doi: 10.1016/j.cpcardiol.2025.103168. Epub 2025 Sep 3. Curr Probl Cardiol. 2025. PMID: 40912344 Review.

Cite

70

Cite

Alteration of cardiac energetics and mitochondrial function in doxorubicin‑induced cardiotoxicity: Molecular mechanism and prospective implications (Review).

Qing G, Huang C, Pei J, Peng B. Qing G, et al. Int J Mol Med. 2025 Nov;56(5):183. doi: 10.3892/ijmm.2025.5624. Epub 2025 Sep 5. Int J Mol Med. 2025. PMID: 40910252 Free PMC article. Review.

Cite

71

Cite

Role of metabolic nuclear receptors in acute liver injury and drug-induced hepatotoxicity.

Nie L, Yan N, Gonzalez FJ, Hao H, Yan T. Nie L, et al. Pharmacol Res. 2025 Oct;220:107942. doi: 10.1016/j.phrs.2025.107942. Epub 2025 Sep 2. Pharmacol Res. 2025. PMID: 40907676 Free article. Review.

Cite

72

Cite

[Frailty and pharmacotherapy].

Eidam A, Seidling HM, Stingl JC, Bauer JM. Eidam A, et al. Inn Med (Heidelb). 2025 Oct;66(10):1025-1031. doi: 10.1007/s00108-025-01980-8. Epub 2025 Sep 3. Inn Med (Heidelb). 2025. PMID: 40900156 Review. German.

Cite

73

Cite

Severe drug-induced liver injury from acipimox and telmisartan co-administration: A case report and review of literature.

Liu D, Liu S. Liu D, et al. Medicine (Baltimore). 2025 Aug 29;104(35):e44184. doi: 10.1097/MD.0000000000044184. Medicine (Baltimore). 2025. PMID: 40898477 Free PMC article. Review.

Cite

74

Cite

Epidermal growth factor receptor inhibitor-related skin toxicities: a review of management and possible preventive and therapeutic approaches for Asian patients by the Japanese Pharmacist-led Oncodermatology Study Team.

Iimura Y, Iihara H, Saito Y, Nomura H, Iwamoto T, Kotera M, Tsuchiya Y, Sumiya T, Kono M, Hirate D, Kurokawa T, Hayashi T, Hashimoto H, Higuchi J, Urakawa R, Saotome H, Kuroda S. Iimura Y, et al. Int J Clin Oncol. 2025 Nov;30(11):2192-2207. doi: 10.1007/s10147-025-02868-1. Epub 2025 Sep 1. Int J Clin Oncol. 2025. PMID: 40888993 Free PMC article. Review.

Cite

75

Cite

Dermatological impacts of urological cancer treatments.

Sataray-Rodriguez A, Oladinni D, Adler R, Doshi N, Patrick B, Aust N, Sun M, Schur N, Jamieson S, P Weiss J. Sataray-Rodriguez A, et al. World J Urol. 2025 Aug 31;43(1):521. doi: 10.1007/s00345-025-05896-8. World J Urol. 2025. PMID: 40887555 Review.

Cite

76

Cite

Trastuzumab Cardiotoxicity: Mechanism and Management.

Wakasa M, Masaki M, Kajinami K. Wakasa M, et al. Biol Pharm Bull. 2025;48(9):1287-1294. doi: 10.1248/bpb.b25-00235. Biol Pharm Bull. 2025. PMID: 40887295 Free article. Review.

Cite

77

Cite

Deciphering transcriptomic changes in chemobrain: a comprehensive review.

Acharya TK, Pan Y, Grace PM, Heijnen CJ, Mahalingam R. Acharya TK, et al. Acta Neuropathol Commun. 2025 Aug 30;13(1):186. doi: 10.1186/s40478-025-02102-z. Acta Neuropathol Commun. 2025. PMID: 40886025 Free PMC article. Review.

Cite

78

Cite

The role of ferroptosis in doxorubicin-induced cardiotoxicity - An update.

Bhadra P, Yadav P, Kaur S, Hanumantharayudu PT, Arunachalam S. Bhadra P, et al. Life Sci. 2025 Nov 1;380:123945. doi: 10.1016/j.lfs.2025.123945. Epub 2025 Aug 28. Life Sci. 2025. PMID: 40885521 Review.

Cite

79

Cite

[Adverse drug reactions in older adults: A review of epidemiology, risk factors and prevention strategies].

Rodriguez-Espeso EA, Verdejo-Bravo C, Cruz-Jentoft AJ. Rodriguez-Espeso EA, et al. Rev Esp Geriatr Gerontol. 2025 Sep-Oct;60(5):101714. doi: 10.1016/j.regg.2025.101714. Epub 2025 Aug 29. Rev Esp Geriatr Gerontol. 2025. PMID: 40885050 Review. Spanish.

Cite

80

Cite

FEATURES OF THE EFFECT OF SCORPION VENOM ON THE IMMUNE DEFENSE SYSTEM OF THE MAMMALIAN LIVER (REVIEW).

Haidai O, Samborska I, Maievskyi O. Haidai O, et al. Georgian Med News. 2025 Jun;(363):212-220. Georgian Med News. 2025. PMID: 40884389 Review.

Cite

81

Cite

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.

Omland T, Heck SL, Holte E, Lilleaasen AM, Gynnild MN, Fagerland MW, Vinje-Jakobsen V, Næs AL, Blix ES, Larsen AI, Geisler J, Gulati G, Wethal T. Omland T, et al. Circulation. 2025 Oct 21;152(16):1136-1145. doi: 10.1161/CIRCULATIONAHA.125.076616. Epub 2025 Aug 29. Circulation. 2025. PMID: 40884047 Free PMC article. Clinical Trial.

Cite

82

Cite

Late Cardiac Toxicity After Anthracyclines and Radiotherapy for Lymphoma-A Regression Analysis of Dose-Response.

Nygård L, Vogelius IR, Kofoed KF, Bentzen S, Specht L. Nygård L, et al. Hematol Oncol. 2025 Sep;43(5):e70134. doi: 10.1002/hon.70134. Hematol Oncol. 2025. PMID: 40874400 Free PMC article.

Cite

83

Cite

VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies.

Corrao S, Moschetti M, Scibetta S, Calvo L, Giardina A, Cangemi I, Zizzo C, Colomba P, Duro G. Corrao S, et al. Int J Mol Sci. 2025 Aug 17;26(16):7931. doi: 10.3390/ijms26167931. Int J Mol Sci. 2025. PMID: 40869252 Free PMC article. Review.

Cite

84

Cite

The Expanding Role of Omalizumab: From Food Allergy to Drug Desensitization.

Kosztulska B, Rydzyńska M, Bartuzi Z, Grześk-Kaczyńska M, Ukleja-Sokołowska N. Kosztulska B, et al. Int J Mol Sci. 2025 Aug 14;26(16):7868. doi: 10.3390/ijms26167868. Int J Mol Sci. 2025. PMID: 40869188 Free PMC article. Review.

Cite

85

Cite

Fatal anaphylactic shock following cefoperazone-sulbactam re-exposure: a short report on systemic gaps in adverse drug reaction management.

Mo X, Liang G, Gan W, Xu L, Yan M. Mo X, et al. BMJ Open Qual. 2025 Aug 27;14(3):e003392. doi: 10.1136/bmjoq-2025-003392. BMJ Open Qual. 2025. PMID: 40866084 Free PMC article. Review.

Cite

86

Cite

Case Report: When dual immune checkpoint blockade strikes back: cadonilimab-induced hypersensitivity in solid tumors - a case series and review.

Song P, Jin Y, Fu L, Yang F, Tan Y. Song P, et al. Front Immunol. 2025 Aug 11;16:1643279. doi: 10.3389/fimmu.2025.1643279. eCollection 2025. Front Immunol. 2025. PMID: 40861473 Free PMC article. Review.

Cite

87

Cite

Immune-related adverse events in immune checkpoint inhibitor therapy for cancer.

Liao K, Martin E, Body A, Yeo AL. Liao K, et al. Intern Med J. 2025 Nov;55(11):1794-1804. doi: 10.1111/imj.70183. Epub 2025 Aug 26. Intern Med J. 2025. PMID: 40856370 Review.

Cite

88

Cite

Impact of PNPLA3 I148M on Drug-Induced Hepatocellular Liver Injury: A Systematic Review and Meta-Analysis.

Gatzios A, Marchandise L, Hagström H, Schattenberg JM, Rodrigues RM, Vanhaecke T, Boeckmans J. Gatzios A, et al. Liver Int. 2025 Sep;45(9):e70287. doi: 10.1111/liv.70287. Liver Int. 2025. PMID: 40851509 Free PMC article.

Cite

89

Cite

Cardiotoxicity in Breast Cancer Therapy: Risks, Mechanisms, and Prevention Strategies.

Fitrianti AE, Wardani NO, Astuti A, Anggadiredja K, Amalia L, Putri RA, Zazuli Z. Fitrianti AE, et al. Med Sci (Basel). 2025 Aug 14;13(3):130. doi: 10.3390/medsci13030130. Med Sci (Basel). 2025. PMID: 40843752 Free PMC article. Review.

Cite

90

Cite

HLA-B*58:01 genotyping prevalence and the association with allopurinol-induced severe cutaneous adverse reactions: a living systematic review and meta-analysis.

Pham HT, Tran MH, Mai Hoang TV, Nguyen AH, Tran MH. Pham HT, et al. Sci Rep. 2025 Aug 21;15(1):30742. doi: 10.1038/s41598-025-16062-w. Sci Rep. 2025. PMID: 40841814 Free PMC article.

Cite

91

Cite

Cancer therapy-induced cardiac metabolic reprogramming: A new frontier in cardio-oncology.

Lang Z, Zhao J, Dong K, Zhao Y, Bai L, Cong Q, Chen C, Wang Y, Tang J, Bai M. Lang Z, et al. Int Immunopharmacol. 2025 Oct 30;164:115397. doi: 10.1016/j.intimp.2025.115397. Epub 2025 Aug 23. Int Immunopharmacol. 2025. PMID: 40850204 Review.

Cite

92

Cite

Association Between ABCG2 Polymorphism and Statin-Induced Adverse Events: A Meta-Analysis.

Lee DH, Shin HJ, Yoon B, Kim HW, Jo HW, Kim HJ, Kim W. Lee DH, et al. Cardiovasc Toxicol. 2025 Nov;25(11):1761-1767. doi: 10.1007/s12012-025-10056-w. Epub 2025 Aug 23. Cardiovasc Toxicol. 2025. PMID: 40848094

Cite

93

Cite

Xenobiotic-induced liver injury: Molecular mechanisms and disease progression.

Wang L, Shao Z, Wang X, Lu W, Sun H. Wang L, et al. Ecotoxicol Environ Saf. 2025 Sep 15;303:118854. doi: 10.1016/j.ecoenv.2025.118854. Epub 2025 Aug 21. Ecotoxicol Environ Saf. 2025. PMID: 40845633 Free article. Review.

Cite

94

Cite

Hospital admissions due to adverse drug reactions and adverse drug events in older adults: a systematic review.

Cosgrave N, Frydenlund J, Beirne F, Lee S, Faez I, Cahir C, Williams D. Cosgrave N, et al. Age Ageing. 2025 Aug 1;54(8):afaf231. doi: 10.1093/ageing/afaf231. Age Ageing. 2025. PMID: 40838776 Free PMC article.

Cite

95

Cite

Direct penicillin allergy challenge.

[No authors listed] [No authors listed] Drug Ther Bull. 2025 Oct 27;63(11):163. doi: 10.1136/dtb.2025.000037. Drug Ther Bull. 2025. PMID: 40829860

Cite

96

Cite

[Expert consensus statement on prevention and management of cancer therapy-related cardiac dysfunction].

Chinese Society of Cardiology, Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology. Chinese Society of Cardiology, Chinese Medical Association, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2025 Aug 24;53(8):855-871. doi: 10.3760/cma.j.cn112148-20240816-00461. Zhonghua Xin Xue Guan Bing Za Zhi. 2025. PMID: 40825727 Chinese.

Cite

97

Cite

Quality indicators for safe and effective use of medications in long-term care settings: A systematic review.

Gutteridge DS, Calder AH, Stasinopoulos J, Javanparast S, Caughey GE, Hillen JB, Stafford AC, Peterson GM, Inacio MC, Khadka J, Kalisch Ellett LM, Jackson SL, Hibbert PD, Cations ML, Corlis ME, Yu SC, Clark MJ, Soulsby NR, Manias E, Yoo GH, Sluggett JK. Gutteridge DS, et al. Br J Clin Pharmacol. 2025 Nov;91(11):3054-3069. doi: 10.1002/bcp.70242. Epub 2025 Aug 18. Br J Clin Pharmacol. 2025. PMID: 40825531 Free PMC article. Review.

Cite

98

Cite

Recent advances of small-molecule fluorescent probes for sensing and imaging biomarkers of experimental intrinsic drug-induced liver injury.

Xi D, Duan G, Liu B, You Y, Zhuang Y, Ye H, Fang M. Xi D, et al. Bioorg Chem. 2025 Sep;164:108871. doi: 10.1016/j.bioorg.2025.108871. Epub 2025 Aug 11. Bioorg Chem. 2025. PMID: 40825255 Review.

Cite

99

Cite

The efficacy of premedication with 10 mg versus 20 mg of intravenous dexamethasone for prevention of paclitaxel hypersensitivity reaction in low-risk gynecologic cancer patients: a non-inferiority, randomized controlled mono-institutional trial.

Sa-Ngiamphorn N, Suprasert P, Charoentum C. Sa-Ngiamphorn N, et al. BMC Cancer. 2025 Aug 16;25(1):1324. doi: 10.1186/s12885-025-14769-7. BMC Cancer. 2025. PMID: 40819065 Free PMC article. Clinical Trial.

Cite

100

Cite

Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes.

Moreno-Torres M, López-Pascual E, Moro E, Rapisarda A, Lindeman B, Verhoeven A, Luechtefeld T, Serrano-Candelas E, Dirven H, Vinken M, Castell JV, Jover R. Moreno-Torres M, et al. Biomed Pharmacother. 2025 Oct;191:118459. doi: 10.1016/j.biopha.2025.118459. Epub 2025 Aug 15. Biomed Pharmacother. 2025. PMID: 40818362 Free article. Review.

Cite

101

Cite

Acute non-hypersensitivity adverse reactions following intravascular administration of contrast agents in adult patients.

van der Molen AJ, Vega F. van der Molen AJ, et al. Eur J Radiol. 2025 Oct;191:112355. doi: 10.1016/j.ejrad.2025.112355. Epub 2025 Aug 6. Eur J Radiol. 2025. PMID: 40818215 Free article. Review.

Cite

102

Cite

Development of a complex 3D in vitro alternative model to evaluate the safety of advanced materials.

Tutty MA, Simone T, Prina-Mello A. Tutty MA, et al. Toxicol Appl Pharmacol. 2025 Nov;504:117520. doi: 10.1016/j.taap.2025.117520. Epub 2025 Aug 14. Toxicol Appl Pharmacol. 2025. PMID: 40816551 Free article. Review.

Cite

103

Cite

Impact of Additional Monitoring on Pharmacovigilance and Pharmacists' Role: A Scoping Review.

Aizpurua-Arruti X, Goyenechea E, Isla A, Oñatibia-Astibia A, Malet-Larrea A, Gastelurrutia MÁ, Solinís MÁ, Del Pozo-Rodriguez A. Aizpurua-Arruti X, et al. Pharmacoepidemiol Drug Saf. 2025 Sep;34(9):e70201. doi: 10.1002/pds.70201. Pharmacoepidemiol Drug Saf. 2025. PMID: 40814839 Free PMC article.

Cite

104

Cite

Skin Reactions and Other Underappreciated Dermatologic Side Effects of Cancer Therapies.

Tran HTT, Tran TM, Le DV, Jacobs JC, Nguyen TM, Trinh HL, Vo BTT, Tran TS, Nguyen GH. Tran HTT, et al. Curr Treat Options Oncol. 2025 Aug;26(8):726-753. doi: 10.1007/s11864-025-01333-5. Epub 2025 Aug 14. Curr Treat Options Oncol. 2025. PMID: 40813519 Review.

Cite

105

Cite

Research on Doxorubicin-Induced Cardiotoxicity Mechanism and Its Forensic Application.

Zhang S, Xu HF, Zhang ZX, Wang Y, Zhu SH. Zhang S, et al. Fa Yi Xue Za Zhi. 2025 Apr 25;41(2):120-126. doi: 10.12116/j.issn.1004-5619.2024.440404. Fa Yi Xue Za Zhi. 2025. PMID: 40813079 Free article. Review. Chinese, English.

Cite

106

Cite

A phase II study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in patients with colorectal cancer receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study).

Iimura Y, Baba K, Furukawa N, Ishibashi M, Sasuga C, Ahiko Y, Monma S, Sakuyama N, Aikou S, Shida D, Nojima M, Kuroda S, Boku N. Iimura Y, et al. Int J Clin Oncol. 2025 Nov;30(11):2316-2324. doi: 10.1007/s10147-025-02857-4. Epub 2025 Aug 14. Int J Clin Oncol. 2025. PMID: 40810825 Free PMC article. Clinical Trial.

Cite

107

Cite

Efficacy and Safety of Twelve Anti-Dyskinetic Drugs in Parkinson's Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Chen FF, Wen SY, Chen XT, Zhang Q, Tao P, Meng C, Huang J, Chen W, Zhou CQ. Chen FF, et al. Eur J Neurol. 2025 Aug;32(8):e70329. doi: 10.1111/ene.70329. Eur J Neurol. 2025. PMID: 40808408 Free PMC article. Review.

Cite

108

Cite

Doxorubicin Toxicity and Recent Approaches to Alleviating Its Adverse Effects with Focus on Oxidative Stress.

Radeva L, Yoncheva K. Radeva L, et al. Molecules. 2025 Aug 7;30(15):3311. doi: 10.3390/molecules30153311. Molecules. 2025. PMID: 40807486 Free PMC article. Review.

Cite

109

Cite

New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?

Shrimali S, Chen M, Li D, Tong W. Shrimali S, et al. Drug Discov Today. 2025 Sep;30(9):104452. doi: 10.1016/j.drudis.2025.104452. Epub 2025 Aug 11. Drug Discov Today. 2025. PMID: 40803573 Free article. Review.

Cite

110

Cite

Application of Mechanistic Mathematical Modeling to Toxicology: Quantitative Systems Toxicology (QST).

Beattie KA, Sher A. Beattie KA, et al. Handb Exp Pharmacol. 2025;289:285-306. doi: 10.1007/164_2025_758. Handb Exp Pharmacol. 2025. PMID: 40802056 Review.

Cite

111

Cite

Cefixime versus benzathine penicillin G for the treatment of early syphilis-a randomized, controlled open label trial.

Klementová T, Zákoucká H, Bížová B, Unemo M, Rob F. Klementová T, et al. J Antimicrob Chemother. 2025 Oct 3;80(10):2654-2658. doi: 10.1093/jac/dkaf268. J Antimicrob Chemother. 2025. PMID: 40795115 Clinical Trial.

Cite

112

Cite

A practical approach to managing agitated toxidromes.

Pannu AK. Pannu AK. Trop Doct. 2025 Oct;55(4):382-384. doi: 10.1177/00494755251362930. Epub 2025 Aug 12. Trop Doct. 2025. PMID: 40791148 Review.

Cite

113

Cite

Effect of Cognitive Training on Cancer-Related Cognitive Impairment in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.

Sánchez-Gómez C, Fernández-Rodríguez EJ, Jiménez-Sánchez S, Fonseca-Sánchez E, Perez J, Navarro-López V, García-Tizón SJ, Sánchez-González JL. Sánchez-Gómez C, et al. Psychooncology. 2025 Aug;34(8):e70251. doi: 10.1002/pon.70251. Psychooncology. 2025. PMID: 40790842 Free PMC article.

Cite

114

Cite

Leveraging Unstructured Data in Electronic Health Records to Detect Adverse Events from Pediatric Drug Use: A Scoping Review.

Golder S, O'Connor K, Lopez-Garcia G, Tatonetti NP, Gonzalez-Hernandez G. Golder S, et al. Annu Rev Biomed Data Sci. 2025 Aug;8(1):227-250. doi: 10.1146/annurev-biodatasci-111224-124530. Annu Rev Biomed Data Sci. 2025. PMID: 40789734 Free article.

Cite

115

Cite

Advances in mechanistic investigation and treatment of steroid-refractory ICI-induced liver injury.

Hu H, Shen X, Chen J. Hu H, et al. Clin Exp Med. 2025 Aug 11;25(1):288. doi: 10.1007/s10238-025-01721-z. Clin Exp Med. 2025. PMID: 40788551 Free PMC article. Review.

Cite

116

Cite

Mast cell conditions and drug allergy.

Olivieri B, Bonadonna P. Olivieri B, et al. Ann Allergy Asthma Immunol. 2025 Nov;135(5):521-529. doi: 10.1016/j.anai.2025.07.030. Epub 2025 Aug 7. Ann Allergy Asthma Immunol. 2025. PMID: 40783101 Review.

Cite

117

Cite

Clozapine-induced cardiac toxicity and successful rechallenge in children and adolescents: a systematic review and new case report.

Biagetti R, Caiazza L, Giuva T, Pirani G, Di Biase AR, Bergonzini P, Caramaschi E, Spezia E, Iughetti L, Lupetti I, Donati C, Persico AM. Biagetti R, et al. Psychiatry Res. 2025 Sep;351:116646. doi: 10.1016/j.psychres.2025.116646. Epub 2025 Jul 18. Psychiatry Res. 2025. PMID: 40780116 Free article. Review.

Cite

118

Cite

Chemotherapy-induced cognitive impairment: Mechanisms, emerging biomarkers, and therapeutic interventions.

Chughtai S, Doyle D, Tata S, Ram D, Oymagil I. Chughtai S, et al. Biochem Biophys Res Commun. 2025 Sep 12;779:152456. doi: 10.1016/j.bbrc.2025.152456. Epub 2025 Aug 6. Biochem Biophys Res Commun. 2025. PMID: 40779978 Review.

Cite

119

Cite

Subcutaneous injections of cabotegravir plus rilpivirine long-acting in virally suppressed adults with HIV-1.

D'Amico R, Han K, Min S, DeMoor R, St Clair M, Ford SL, Harrington C, Bernal-Morell E, Lombaard J, Crauwels H, Kolobova I, Patel N, Jamil N, Van Solingen-Ristea R, Acuipil C, Spreen W. D'Amico R, et al. AIDS. 2025 Dec 1;39(15):2182-2190. doi: 10.1097/QAD.0000000000004310. Epub 2025 Oct 21. AIDS. 2025. PMID: 40779489 Clinical Trial.

Cite

120

Cite

Rapid review of drug induced Stevens Johnson Syndrome case reports from 2003 to 2023: Trends among monoclonal antibodies and systemic immunosuppressant therapy.

Gossell-Williams M, McLaren G, Clarke R, Douglas S, Gayle D, Guthrie K. Gossell-Williams M, et al. Int J Risk Saf Med. 2025 Nov;36(4):156-167. doi: 10.1177/09246479251368022. Epub 2025 Aug 8. Int J Risk Saf Med. 2025. PMID: 40778904 Review.

Cite

121

Cite

Exogenous insulin antibody syndrome in type 2 diabetes with diabetic ketoacidosis: A case report and literature review.

Xu M, Xia L, Xiao R, Deng D. Xu M, et al. Int J Clin Pharmacol Ther. 2025 Nov;63(11):561-566. doi: 10.5414/CP204819. Int J Clin Pharmacol Ther. 2025. PMID: 40776672 Review.

Cite

122

Cite

A new category for understanding the mechanisms of drug-induced kidney injury.

Liu W, Tang Q, Zhang W, Hua A, Ye X. Liu W, et al. Ren Fail. 2025 Dec;47(1):2540563. doi: 10.1080/0886022X.2025.2540563. Epub 2025 Aug 7. Ren Fail. 2025. PMID: 40775804 Free PMC article. Review.

Cite

123

Cite

Pharmacovigilance: Overview of Italian and European regulations, tools, and perspectives.

Castellana E, Budau PM, Chiappetta MR. Castellana E, et al. Int J Risk Saf Med. 2025 Nov;36(4):147-155. doi: 10.1177/09246479251366836. Epub 2025 Aug 7. Int J Risk Saf Med. 2025. PMID: 40773022 Review.

Cite

124

Cite

ANTHRACYCLINE-INDUCED CARDIOTOXICITY: MECHANISM AND PREVENTION.

Yeh ETH, Chang HM. Yeh ETH, et al. Trans Am Clin Climatol Assoc. 2025;135:184-195. Trans Am Clin Climatol Assoc. 2025. PMID: 40771595 Free PMC article. Review.

Cite

125

Cite

2025 New Drug Update: Recent Approvals and Their Clinical Implications.

Lee K, Khartabil N. Lee K, et al. Sr Care Pharm. 2025 Aug 1;40(8):306-314. doi: 10.4140/TCP.n.2025.306. Sr Care Pharm. 2025. PMID: 40770590 Review.

Cite

126

Cite

Characterization of drug-related oral and dental adverse events: Literature vs drug labeling.

Billings M, Lee H, Mendoza JL, Hyman F, Weatherspoon D, Dhar V, Fazilatkhoo F, Zhang Y, Kim K, Choi L, Edelberg H. Billings M, et al. J Am Dent Assoc. 2025 Aug;156(8):638-648.e6. doi: 10.1016/j.adaj.2025.05.016. J Am Dent Assoc. 2025. PMID: 40769649

Cite

127

Cite

Vitamin C as a Cardioprotective Agent Against Doxorubicin-Induced Cardiotoxicity.

Nsairat H, Lafi Z, Abualsoud BM, Al-Najjar BO, Al-Samydai A, Oriquat GA, Alshaer W, Alqader Ibrahim A, Dellinger AL. Nsairat H, et al. J Am Heart Assoc. 2025 Aug 19;14(16):e042534. doi: 10.1161/JAHA.125.042534. Epub 2025 Aug 6. J Am Heart Assoc. 2025. PMID: 40767287 Free PMC article. Review.

Cite

128

Cite

Pharmacological interventions for anthracycline-induced cardiotoxicity in breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Vacharanukrauh P, Miller KJ, Alif SM, Grace F, Rahman MA. Vacharanukrauh P, et al. Breast Cancer Res Treat. 2025 Nov;214(1):1-23. doi: 10.1007/s10549-025-07791-7. Epub 2025 Aug 5. Breast Cancer Res Treat. 2025. PMID: 40762867 Free PMC article.

Cite

129

Cite

Drug-induced Liver Injury: Pathology Patterns and Common Culprits.

Parrack PH, Zhao L. Parrack PH, et al. Adv Anat Pathol. 2025 Nov 1;32(6):402-413. doi: 10.1097/PAP.0000000000000506. Epub 2025 Aug 4. Adv Anat Pathol. 2025. PMID: 40757478 Review.

Cite

130

Cite

[Vestibulopathies and adult cancers: A literature review].

Maquet C, Crampon C, Tendron A, Giraudet F, Ferrand FR, Horion J, Nebbache R, Crampon F, Deneuve S. Maquet C, et al. Bull Cancer. 2025 Oct;112(10):1183-1192. doi: 10.1016/j.bulcan.2025.03.006. Epub 2025 Aug 5. Bull Cancer. 2025. PMID: 40753050 Free article. Review. French.

Cite

131

Cite

Medication Safety in Acute Care Settings.

Vasilevskis EE, Chui MA, Mai S, Kripalani S. Vasilevskis EE, et al. Med Clin North Am. 2025 Sep;109(5):1029-1045. doi: 10.1016/j.mcna.2025.02.010. Epub 2025 Apr 7. Med Clin North Am. 2025. PMID: 40752928 Review.

Cite

132

Cite

The evolving role of multimodal imaging, artificial intelligence and radiomics in the radiologic assessment of immune related adverse events.

Das JP, Ma HY, de Jong D, Prendergast C, Baniasadi A, Braumuller B, Giarratana A, Khonji MS, Paily J, Shobeiri P, Yeh R, Dercle L, Capaccione KM. Das JP, et al. Clin Imaging. 2025 Sep;125:110571. doi: 10.1016/j.clinimag.2025.110571. Epub 2025 Jul 28. Clin Imaging. 2025. PMID: 40743785 Review.

Cite

133

Cite

Prevalence of Positive Penicillin Allergy Testing in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis.

Ouranos K, Mylonakis SC, Mylona EK, Shehadeh F, Motazedi T, Huston DP. Ouranos K, et al. J Allergy Clin Immunol Pract. 2025 Oct;13(10):2728-2744. doi: 10.1016/j.jaip.2025.07.027. Epub 2025 Jul 28. J Allergy Clin Immunol Pract. 2025. PMID: 40738396

Cite

134

Cite

Drug-Induced Retinal Toxicity.

Vyas C, Jolia A, Tsang SH, Sharma T, Diaconita V. Vyas C, et al. Adv Exp Med Biol. 2025;1467:253-262. doi: 10.1007/978-3-031-72230-1_50. Adv Exp Med Biol. 2025. PMID: 40736852 Review.

Cite

135

Cite

Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool.

Algarvio RC, Conceição J, Rodrigues PP, Ribeiro I, Ferreira-da-Silva R. Algarvio RC, et al. Int J Clin Pharm. 2025 Aug;47(4):932-944. doi: 10.1007/s11096-025-01975-3. Epub 2025 Jul 30. Int J Clin Pharm. 2025. PMID: 40736603 Free PMC article. Review.

Cite

136

Cite

Assessing the Impact of Pharmacists' Interventions on Preventing and Resolving Drug-Related Problems in Cancer Pain Management.

Pradhan S, Kashyap LL. Pradhan S, et al. Asian Pac J Cancer Prev. 2025 Jul 1;26(7):2585-2591. doi: 10.31557/APJCP.2025.26.7.2585. Asian Pac J Cancer Prev. 2025. PMID: 40729081 Free PMC article. Clinical Trial.

Cite

137

Cite

Efficacy of Aspirin Therapy After Desensitization on Chronic Rhinosinusitis With Nasal Polyps Patients With Asthma and Non-steroidal Anti-inflammatory Drug Exacerbated Respiratory Disease -A Randomized Clinical Trial.

Helevä A, Lyly A, Salmi V, Mäkelä M, Kauppi P, Laulajainen-Hongisto A, Hafrén L, Virkkula P, Nuutinen M, Toppila-Salmi S. Helevä A, et al. Allergy. 2025 Nov;80(11):3151-3164. doi: 10.1111/all.16679. Epub 2025 Jul 29. Allergy. 2025. PMID: 40726272 Free PMC article. Clinical Trial.

Cite

138

Cite

Toxic epidermal necrolysis following lamotrigine replacement therapy in a woman planning pregnancy: a case report and literature review.

Zhang L, Yang P, Zhu Y, Liu K, Sun Z. Zhang L, et al. BMC Womens Health. 2025 Jul 28;25(1):371. doi: 10.1186/s12905-025-03796-y. BMC Womens Health. 2025. PMID: 40717110 Free PMC article. Review.

Cite

139

Cite

Nicolau syndrome in a pediatric patient after corticosteroid injection: a case report and review of the literature.

Abtahi-Naeini B, Babaie S, Seyedyousefi S, Ahmadinia F. Abtahi-Naeini B, et al. J Med Case Rep. 2025 Jul 27;19(1):370. doi: 10.1186/s13256-025-05437-2. J Med Case Rep. 2025. PMID: 40717070 Free PMC article. Review.

Cite

140

Cite

Polypharmacy as a reason for misinterpreting laboratory results in the elderly.

İncir S, Bolayirli M. İncir S, et al. Adv Pharmacol. 2025;104:515-581. doi: 10.1016/bs.apha.2025.05.001. Epub 2025 May 28. Adv Pharmacol. 2025. PMID: 40716941 Review.

Cite

141

Cite

Evaluating the role of clinical decision support systems in medication safety for older people: a systematic review.

Ng Y, Hsu JTY, Ng NNE, Ong JZE, Hsu JLJ, Sulaimi F, Tan HK, Tang ASP, Ng QX. Ng Y, et al. Age Ageing. 2025 Jul 1;54(7):afaf206. doi: 10.1093/ageing/afaf206. Age Ageing. 2025. PMID: 40716041 Free PMC article.

Cite

142

Cite

[Overview of clinical manifestations, diagnosis and management of acute allergic disorders].

Stadler PC, Gust C, Weißinger S, French LE, Oppel EM. Stadler PC, et al. Dermatologie (Heidelb). 2025 Aug;76(8):507-515. doi: 10.1007/s00105-025-05535-8. Epub 2025 Jul 28. Dermatologie (Heidelb). 2025. PMID: 40719879 Review. German.

Cite

143

Cite

Stellate Ganglion Block for Management of Nicolau's Syndrome Following Intravenous Ibuprofen Injection: a Case Report and Literature Review.

Shehata IM, Hassan SA, Rabie RAE, Hasoon J, Abd-Elhak AA. Shehata IM, et al. Curr Pain Headache Rep. 2025 Jul 26;29(1):103. doi: 10.1007/s11916-025-01407-x. Curr Pain Headache Rep. 2025. PMID: 40715857 Review.

Cite

144

Cite

Update on desensitization to chemotherapeutics and biologicals.

Caiado J, Castells MC. Caiado J, et al. Ann Allergy Asthma Immunol. 2025 Oct;135(4):374-382. doi: 10.1016/j.anai.2025.07.018. Epub 2025 Jul 24. Ann Allergy Asthma Immunol. 2025. PMID: 40714312 Review.

Cite

145

Cite

Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades?

Avagimyan A, Madonna R, Sheibani M, Pogosova N, Trofimenko A, Urazova O, Iop L, Jndoyan Z, Yeranosyan H, Aznauryan A, Sahakyan K, Petrosyan A, Petrosyan R, Tatoyan M, Mkrtchyan G, Sulemaniayants E, Meltonyan G, Kuzniatsou A, Mukherjee R, Rezabakhsh A, Koliakos G, Ottaviani G, Zoccai GB, Sarrafzadegan N. Avagimyan A, et al. Vascul Pharmacol. 2025 Sep;160:107526. doi: 10.1016/j.vph.2025.107526. Epub 2025 Jul 24. Vascul Pharmacol. 2025. PMID: 40714257 Review.

Cite

146

Cite

Herbal management of TAA-induced liver toxicity: Fibrosis, cirrhosis, and hepatocellular carcinoma.

Mohamed AA, Shoun AA, El-Kadi RA, Abd El-Maseh SO, Abass SA. Mohamed AA, et al. Pathol Res Pract. 2025 Sep;273:156141. doi: 10.1016/j.prp.2025.156141. Epub 2025 Jul 23. Pathol Res Pract. 2025. PMID: 40712261 Review.

Cite

147

Cite

[Radiation-induced ototoxicity during the treatment of head, neck and skull base cancers].

Nebbache R, Huguet F, Thariat J, Maquet C, Giraudet F, Ferrand FR. Nebbache R, et al. Bull Cancer. 2025 Oct;112(10):1172-1182. doi: 10.1016/j.bulcan.2025.06.007. Epub 2025 Jul 23. Bull Cancer. 2025. PMID: 40707277 Free article. Review. French.

Cite

148

Cite

Risk factors of immune checkpoint inhibitor-related cardiotoxicity: a scoping review.

Wang Y, Zhang L, Su Z, Lian X. Wang Y, et al. Oncologist. 2025 Jul 4;30(7):oyaf187. doi: 10.1093/oncolo/oyaf187. Oncologist. 2025. PMID: 40704609 Free PMC article.

Cite

149

Cite

Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper.

Cortellini G, Nakonechna A, Barbaud A, Bavbek S, Calogiuri G, Doña I, Kvedariene V, Laguna Martinez JJ, Liberati S, Pagani M, Romano A. Cortellini G, et al. Allergy. 2025 Nov;80(11):2973-2987. doi: 10.1111/all.16663. Epub 2025 Jul 24. Allergy. 2025. PMID: 40704552 Free PMC article. Review.

Cite

150

Cite

[Pharmaceutical interventions in the new medicine service].

Borja Ripoll S, Mocholí Belenguer F, Traver Salcedo V. Borja Ripoll S, et al. Farm Comunitarios. 2025 Jun 18;17(3):17-25. doi: 10.33620/FC.2173-9218.(2025).19. eCollection 2025 Jul 15. Farm Comunitarios. 2025. PMID: 40703483 Free PMC article. Review. Spanish.

Cite

151

Cite

Landscape of non-coding RNAs in cancer treatment-induced cardiovascular toxicity: From mechanistic insights to clinical implications.

Chen Y, Ye Z, He RQ, Chen G, Zhang DX. Chen Y, et al. Semin Cancer Biol. 2025 Oct;115:16-39. doi: 10.1016/j.semcancer.2025.07.009. Epub 2025 Jul 21. Semin Cancer Biol. 2025. PMID: 40701454 Free article. Review.

Cite

152

Cite

Age-dependent differences in anaphylaxis: elderly population.

Barone A, Nicoletta F, Ottoni M, Ridolo E. Barone A, et al. Curr Opin Allergy Clin Immunol. 2025 Oct 1;25(5):343-348. doi: 10.1097/ACI.0000000000001091. Epub 2025 Aug 11. Curr Opin Allergy Clin Immunol. 2025. PMID: 40699586 Free PMC article. Review.

Cite

153

Cite

Skin manifestations in perioperative hypersensitivity: state of the art.

Lim XR, Thong BY. Lim XR, et al. Curr Opin Allergy Clin Immunol. 2025 Oct 1;25(5):404-410. doi: 10.1097/ACI.0000000000001094. Epub 2025 Jul 23. Curr Opin Allergy Clin Immunol. 2025. PMID: 40699342 Review.

Cite

154

Cite

Sulfonamide Allergy and Alternative Treatments in Ocular Toxoplasmosis.

Casado FC, Samper AD. Casado FC, et al. Rom J Ophthalmol. 2025 Apr-Jun;69(2):147-157. doi: 10.22336/rjo.2025.25. Rom J Ophthalmol. 2025. PMID: 40698108 Free PMC article. Review.

Cite

155

Cite

How are prescribing cascades defined in the literature? A scoping review.

Dalton K, Evrard P, Moriarty F, O'Mahony A, Horan R, Byrne S, McCarthy LM. Dalton K, et al. Res Social Adm Pharm. 2025 Dec;21(12):1042-1049. doi: 10.1016/j.sapharm.2025.07.001. Epub 2025 Jul 12. Res Social Adm Pharm. 2025. PMID: 40683828 Free article. Review.

Cite

156

Cite

Emerging threat of environmental microplastics: A comprehensive analysis of hepatic metabolic dysregulation and hepatocellular damage (Review).

Yue S, Chen S, Zhang Y, Chen B, Xu T. Yue S, et al. Int J Mol Med. 2025 Oct;56(4):144. doi: 10.3892/ijmm.2025.5584. Epub 2025 Jul 19. Int J Mol Med. 2025. PMID: 40682833 Free PMC article. Review.

Cite

157

Cite

Ubiquitination: A non-negligible modulator in doxorubicin-induced cardiotoxicity.

Gao C, Lu C, Wei J, Mu Z, Sun M, Dong D, Liu Z. Gao C, et al. Chem Biol Interact. 2025 Oct 8;419:111664. doi: 10.1016/j.cbi.2025.111664. Epub 2025 Jul 15. Chem Biol Interact. 2025. PMID: 40675406 Review.

Cite

158

Cite

The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial.

Stone CA Jr, Prigmore HL, McCoy AB, Stollings JL, Dear ML, Hiser W, Van Winkle G, Kripalani S, Wright A, Harrell FE, Rice TW, Lindsell CJ, Phillips EJ; Vanderbilt Learning Healthcare System Platform Investigators. Stone CA Jr, et al. J Allergy Clin Immunol Pract. 2025 Oct;13(10):2747-2755. doi: 10.1016/j.jaip.2025.07.006. Epub 2025 Jul 16. J Allergy Clin Immunol Pract. 2025. PMID: 40675326 Free article. Clinical Trial.

Cite

159

Cite

The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2).

Hagens L, Bevers LAH, Malaba TR, Nassiwa SC, Mrubata M, Theunissen H, Reynolds H, He N, Read J, Burger DM, Lamorde M, Myer L, Wang D, Khoo S, Waitt C, Colbers A. Hagens L, et al. Pediatr Infect Dis J. 2025 Nov 1;44(11):1066-1071. doi: 10.1097/INF.0000000000004902. Epub 2025 Jul 18. Pediatr Infect Dis J. 2025. PMID: 40674650 Free PMC article. Clinical Trial.

Cite

160

Cite

Empowering patients through pharmacovigilance, transparency, and health literacy: a narrative review.

De Jesus M, Rabbani G, Ferrer B, Assaf AR, Bader M, South BR, Leventhal DP, Boyles P, Watt SJ, Habtezion A. De Jesus M, et al. Curr Med Res Opin. 2025 Jul;41(7):1249-1259. doi: 10.1080/03007995.2025.2534468. Epub 2025 Jul 28. Curr Med Res Opin. 2025. PMID: 40671348 Free article. Review.

Cite

161

Cite

Hepatotoxicity of Chemotherapy and Immune Checkpoint Inhibitors.

Block PD, Assis DN. Block PD, et al. Clin Liver Dis. 2025 Aug;29(3):483-501. doi: 10.1016/j.cld.2025.03.006. Epub 2025 May 12. Clin Liver Dis. 2025. PMID: 40670034 Review.

Cite

162

Cite

Epidemiology of Antiretroviral Therapy Related Adverse Drug Reactions and its Predictors Among Patients with Human Immunodeficiency Virus/AIDS in Ethiopia: A Systematic Review and Meta-analysis.

Zewdu WS, Dagnew SB, Zeleke MM, Ferede YA, Kassie AB, Moges TA, Alemu MA. Zewdu WS, et al. J Int Assoc Provid AIDS Care. 2025 Jan-Dec;24:23259582251358929. doi: 10.1177/23259582251358929. Epub 2025 Jul 15. J Int Assoc Provid AIDS Care. 2025. PMID: 40665675 Free PMC article.

Cite

163

Cite

Positive social modeling attenuates nocebo side effects.

Saunders C, Tan W, Ng D, Burchett A, McNair N, Colagiuri B. Saunders C, et al. Ann Behav Med. 2025 Jan 4;59(1):kaaf048. doi: 10.1093/abm/kaaf048. Ann Behav Med. 2025. PMID: 40662257 Free PMC article. Clinical Trial.

Cite

164

Cite

Efficacy and Safety of Etanercept in Japanese Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Unresponsive to Systemic Steroid Therapy: A Multicenter, Open-Label, Single-Arm Study.

Kimura H, Oginezawa M, Hama N, Watanabe Y, Yamaguchi Y, Nakajima S, Watanabe H, Abe R. Kimura H, et al. J Dermatol. 2025 Oct;52(10):1536-1544. doi: 10.1111/1346-8138.17860. Epub 2025 Jul 14. J Dermatol. 2025. PMID: 40657848 Clinical Trial.

Cite

165

Cite

Immunotherapy-Induced Cardiotoxicity: A Narrative Review of Real-World Case Reports, Recent Information and Clinical Evidence.

Ogunniyi KE, Djunadi TA, Adewara O, Babawale I, Akinmoju OD, Olaiya VO, Nwatamole B, Shazad S, Patel D, Popoola HA, Onaolapo D, Gold-Olufadi S, Ogieuhi IJ, Nfonoyim J. Ogunniyi KE, et al. Cardiovasc Toxicol. 2025 Sep;25(9):1381-1410. doi: 10.1007/s12012-025-10038-y. Epub 2025 Jul 13. Cardiovasc Toxicol. 2025. PMID: 40652443 Review.

Cite

166

Cite

A Randomized Trial Comparing Direct Challenges to Penicillin Skin Testing for Outpatient Low-Risk Penicillin Allergy Evaluations in Pregnancy.

Patrawala S, Mustafa SS, Kraude R, Ramsey A. Patrawala S, et al. J Allergy Clin Immunol Pract. 2025 Sep;13(9):2405-2410.e1. doi: 10.1016/j.jaip.2025.07.003. Epub 2025 Jul 9. J Allergy Clin Immunol Pract. 2025. PMID: 40645375 Clinical Trial.

Cite

167

Cite

Non-coding RNAs in cancer therapy-induced cardiotoxicity: Unlocking precision biomarkers for early detection.

Singh DD, Yadav DK, Shin D. Singh DD, et al. Cell Signal. 2025 Nov;135:111982. doi: 10.1016/j.cellsig.2025.111982. Epub 2025 Jul 9. Cell Signal. 2025. PMID: 40645315 Review.

Cite

168

Cite

Anthracyclines as diagnostic stressors: mitophagy signaling and hidden cardiac vulnerability.

Kulicka N, Dziewierz A. Kulicka N, et al. Pharmacol Rep. 2025 Oct;77(5):1273-1282. doi: 10.1007/s43440-025-00760-3. Epub 2025 Jul 11. Pharmacol Rep. 2025. PMID: 40643780 Review.

Cite

169

Cite

Regional limb cooling for the prevention of chemotherapy-induced toxicities: a narrative review.

Mallela T, Kaufman L, Dulmage B. Mallela T, et al. Support Care Cancer. 2025 Jul 10;33(8):678. doi: 10.1007/s00520-025-09689-y. Support Care Cancer. 2025. PMID: 40640629 Free PMC article. Review.

Cite

170

Cite

Statins: Novel Approaches for the Management of Doxorubicin-Induced Cardiotoxicity-A Literature Review.

TamehriZadeh SS, Khalaji M, Tajdari M, Mavaddat H, Szmit S, Lashgari NA, Roudsari NM, Abbasi-Kashkoli H, Banach M, Abdolghaffari AH. TamehriZadeh SS, et al. Cardiovasc Toxicol. 2025 Sep;25(9):1429-1452. doi: 10.1007/s12012-025-10030-6. Epub 2025 Jul 10. Cardiovasc Toxicol. 2025. PMID: 40637833 Review.

Cite

171

Cite

Nanozymes: new strategy for the management drug-induced acute liver injury.

Kan M, Wang Y, Cheng N, Huang K, He X. Kan M, et al. J Mater Chem B. 2025 Jul 30;13(30):9023-9042. doi: 10.1039/d5tb00448a. J Mater Chem B. 2025. PMID: 40637149 Review.

Cite

172

Cite

Sirtuin-3 Regulates the Mechanism of Doxorubicin-induced Cardiotoxicity.

Zhang C, Shi D, Yang P. Zhang C, et al. Int Heart J. 2025 Jul 31;66(4):527-539. doi: 10.1536/ihj.24-546. Epub 2025 Jul 9. Int Heart J. 2025. PMID: 40634060 Free article. Review.

Cite

173

Cite

A simple patch test (empty tablet cover patch test) demonstrating ornidazone as offending agent in a patient of fixed drug eruption: Report of a clinical case, a new modified technique and systematic review of literature.

Balamurugan R, Sarma P, Nagendran P, Nicodemus DS, Sharma S. Balamurugan R, et al. Indian J Pharmacol. 2025 May 1;57(3):179-186. doi: 10.4103/ijp.ijp_708_22. Epub 2025 Jul 9. Indian J Pharmacol. 2025. PMID: 40632095 Free PMC article.

Cite

174

Cite

Non-leprosy related dapsone hypersensitivity syndrome: A case report and literature review.

Zhu HQ, Jiang SH, Song GL. Zhu HQ, et al. Medicine (Baltimore). 2025 Jul 4;104(27):e43073. doi: 10.1097/MD.0000000000043073. Medicine (Baltimore). 2025. PMID: 40629627 Free PMC article. Review.

Cite

175

Cite

Analyzing pharmacogenetics cost effectiveness and savings across common health conditions in the United States.

Patel MS, Cicali EJ, Orlando FA. Patel MS, et al. Pharmacogenomics J. 2025 Jul 8;25(4):18. doi: 10.1038/s41397-025-00376-z. Pharmacogenomics J. 2025. PMID: 40628702 Review.

Cite

176

Cite

Safety of Permissive Cardiotoxicity of Trastuzumab in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.

Taha AM, Odat RM, Moawad WAE, Saed SAA, Amer BE, Nguyen D, Salem DS, Tran L, Kassem L. Taha AM, et al. Cardiovasc Toxicol. 2025 Sep;25(9):1369-1380. doi: 10.1007/s12012-025-10037-z. Epub 2025 Jul 8. Cardiovasc Toxicol. 2025. PMID: 40627298 Free PMC article.

Cite

177

Cite

The Cardiovascular Burden of Gonadotropin-Releasing Hormone (GnRH) Therapy: Mechanisms, Risks, and Interventions.

Miraj S, Forood AMK, Azimi S, Panahinia P, Ebadi E, Moradpanah S, Nayebzadeh M, Etezadi A. Miraj S, et al. Cardiovasc Toxicol. 2025 Sep;25(9):1411-1428. doi: 10.1007/s12012-025-10025-3. Epub 2025 Jul 7. Cardiovasc Toxicol. 2025. PMID: 40624439 Review.

Cite

178

Cite

One-bag protocol for cancer drug hypersensitivity: A meta-analysis of safety and effectiveness.

Noyola-Pérez A, González-Díaz SN, Macouzet-Sánchez C, Alanís-Alvarez JM, Muñoz-Silva V, Guzmán-Avilán RI, Macias-Weinmann A, De Lira-Quezada CE, Acuña-Ortega N, Morais-Almeida M, Ansotegui IJ. Noyola-Pérez A, et al. Ann Allergy Asthma Immunol. 2025 Nov;135(5):578-587.e6. doi: 10.1016/j.anai.2025.06.034. Epub 2025 Jul 5. Ann Allergy Asthma Immunol. 2025. PMID: 40623523 Free article.

Cite

179

Cite

Protective effect of celecoxib against capecitabine induced hand and foot syndrome in patients with colorectal Cancer.

Kettana AM, Mostafa TM, Ghannam AA, El-Afify DR. Kettana AM, et al. Cancer Chemother Pharmacol. 2025 Jul 7;95(1):72. doi: 10.1007/s00280-025-04794-5. Cancer Chemother Pharmacol. 2025. PMID: 40622571 Clinical Trial.

Cite

180

Cite

Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review.

Shang W, Li XH, Zeng LH, Li Z, Hu Y, Wen HM, Cao FJ, Wan GX. Shang W, et al. Drug Des Devel Ther. 2025 Jul 1;19:5553-5596. doi: 10.2147/DDDT.S535517. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40620466 Free PMC article. Review.

Cite

181

Cite

Diagnosis and management of reactive infectious mucocutaneous eruption.

Damari N, Goodman A, Bridges C. Damari N, et al. J Hosp Med. 2025 Nov;20(11):1212-1216. doi: 10.1002/jhm.70099. Epub 2025 Jul 7. J Hosp Med. 2025. PMID: 40619921 Free PMC article. Review.

Cite

182

Cite

Core Concepts in Pharmacoepidemiology: Multi-Database Distributed Data Networks.

Haber R, Webster-Clark M, Pratt N, Barclay N, Li X, Maro JC, Platt RW, Prieto-Alhambra D, Filion KB. Haber R, et al. Pharmacoepidemiol Drug Saf. 2025 Jul;34(7):e70177. doi: 10.1002/pds.70177. Pharmacoepidemiol Drug Saf. 2025. PMID: 40619597 Free PMC article. Review.

Cite

183

Cite

Cardiac and vascular toxicity of amivantamab in non-small cell lung cancer (NSCLC): A systematic review.

Papassotiriou I, Tentolouris A, Liontos M, Briasoulis A, Gavriatopoulou M, Ntanasis-Stathopoulos I. Papassotiriou I, et al. Crit Rev Oncol Hematol. 2025 Sep;213:104835. doi: 10.1016/j.critrevonc.2025.104835. Epub 2025 Jul 3. Crit Rev Oncol Hematol. 2025. PMID: 40617324 Free article. Review.

Cite

184

Cite

Penicillin Allergy De-Labeling in Older Adults and Long-Term Care Residents: A Clinical Review.

Shah RJ, Smith LR, Norton DT, Eippert ML, Borzecki AM, Blumenthal KG. Shah RJ, et al. J Am Geriatr Soc. 2025 Oct;73(10):3234-3244. doi: 10.1111/jgs.19619. Epub 2025 Jul 5. J Am Geriatr Soc. 2025. PMID: 40616475 Review.

Cite

185

Cite

Recent and on-going trials for the treatment of levodopa-induced dyskinesia: a review of the clinical trial databases.

Al-Kassmy J, Alsalmi M, Kang W, Palayew M, Huot P. Al-Kassmy J, et al. Neurodegener Dis Manag. 2025 Oct;15(5):235-244. doi: 10.1080/17582024.2025.2528557. Epub 2025 Jul 5. Neurodegener Dis Manag. 2025. PMID: 40616455 Review.

Cite

186

Cite

Optimizing dose selection for doxorubicin-induced cardiotoxicity in mice: A comprehensive analysis of single and multiple-dose regimens.

Li M, Zhang Y, Wu B, Qiu R, Zhao C, Chen B, Shang H. Li M, et al. Eur J Pharmacol. 2025 Sep 15;1003:177883. doi: 10.1016/j.ejphar.2025.177883. Epub 2025 Jul 2. Eur J Pharmacol. 2025. PMID: 40615106

Cite

187

Cite

Cardioprotective strategies against doxorubicin-induced cardiotoxicity: A review from standard therapies to emerging mitochondrial transplantation.

Ito-Hagiwara K, Hagiwara J, Endo Y, Becker LB, Hayashida K. Ito-Hagiwara K, et al. Biomed Pharmacother. 2025 Aug;189:118315. doi: 10.1016/j.biopha.2025.118315. Epub 2025 Jul 3. Biomed Pharmacother. 2025. PMID: 40614534 Free article. Review.

Cite

188

Cite

["Chemobrain": Neurocognitive dysfunction associated with chemotherapy].

Szekeres T, Dank M, Szentmartoni G, Virag M. Szekeres T, et al. Neuropsychopharmacol Hung. 2025 Jun;27(2):106-114. Neuropsychopharmacol Hung. 2025. PMID: 40608293 Free article. Review. Hungarian.

Cite

189

Cite

Drugs and Healthy Aging.

Hilmer SN, Ferrucci L, Cherubini A. Hilmer SN, et al. Drugs Aging. 2025 Jul;42(7):591-598. doi: 10.1007/s40266-025-01208-2. Epub 2025 Jul 3. Drugs Aging. 2025. PMID: 40608209 Free PMC article. Review.

Cite

190

Cite

Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping review.

Scherkl C, Dierkes T, Metzner M, Czock D, Seidling HM, Haefeli WE, Meid AD. Scherkl C, et al. BMC Med Inform Decis Mak. 2025 Jul 2;25(1):244. doi: 10.1186/s12911-025-03096-3. BMC Med Inform Decis Mak. 2025. PMID: 40604894 Free PMC article.

Cite

191

Cite

Traditional Chinese medicine protects against doxorubicin cardiotoxicity via epigenetic modification and beyond.

Zhou J, Liu H, Jiang F, Yu X, Wang P, Wu X. Zhou J, et al. Phytomedicine. 2025 Sep;145:157020. doi: 10.1016/j.phymed.2025.157020. Epub 2025 Jun 25. Phytomedicine. 2025. PMID: 40602291 Review.

Cite

192

Cite

Signals of Adverse Reactions to Herbal Medicines: Evidence and Document Analysis Based on a Scoping Review.

Sartori D, Aronson JK, Brand JS, Gauffin O, Hedfors Vidlin S, Norén GN, Onakpoya IJ. Sartori D, et al. Drug Saf. 2025 Dec;48(12):1339-1352. doi: 10.1007/s40264-025-01580-3. Epub 2025 Jul 2. Drug Saf. 2025. PMID: 40601107 Free PMC article.

Cite

193

Cite

A recent decade update on combating doxorubicin-induced toxicities.

Sritharan S, Sivalingam N. Sritharan S, et al. Arch Toxicol. 2025 Sep;99(9):3565-3578. doi: 10.1007/s00204-025-04112-1. Epub 2025 Jul 2. Arch Toxicol. 2025. PMID: 40600983 Review.

Cite

194

Cite

Cardio-Oncology Considerations for Breast Cancer: Risk Stratification, Monitoring, and Treatment.

Wallins J, Saravia S, Bolaji O, Shaikh Z, Yu A. Wallins J, et al. Oncology (Williston Park). 2025 Jun 16;null(5):188-197. doi: 10.46883/2025.25921044. Oncology (Williston Park). 2025. PMID: 40600749 Free article. Review.

Cite

195

Cite

Treatment of pemphigus and other neglected skin conditions with PC111, a human anti-Fas Ligand monoclonal antibody: a potential disease modifier.

Lotti R, Amato A, Bennett B, Zanocco-Marani T, Marconi A, Pincelli C. Lotti R, et al. J Dermatolog Treat. 2025 Dec;36(1):2526075. doi: 10.1080/09546634.2025.2526075. Epub 2025 Jul 2. J Dermatolog Treat. 2025. PMID: 40600400 Free article. Review.

Cite

196

Cite

Cardiotoxicity in cancer immunotherapy: a systematic review and global meta-analysis.

Zhou F, Liu G, Zhang S, Luo C, Hu S, Wan S, Xiong W, Zhao L. Zhou F, et al. J Transl Med. 2025 Jul 1;23(1):718. doi: 10.1186/s12967-025-06768-w. J Transl Med. 2025. PMID: 40598522 Free PMC article.

Cite

197

Cite

Management of infection and ocular complications in pediatric SJS/TEN-like acute graft-versus-host disease: a clinical case study and literature review.

Yan H, Mo Y, Li Y, Li Q, Luo L, Meng Q, Jia L, Zhou L, Xiao L, Fu X. Yan H, et al. Front Immunol. 2025 Jun 16;16:1588297. doi: 10.3389/fimmu.2025.1588297. eCollection 2025. Front Immunol. 2025. PMID: 40589744 Free PMC article. Review.

Cite

198

Cite

Clinical diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: An EAACI position paper.

Kuyucu S, Blanca-Lopez N, Caubet JC, Moral L, Sousa-Pinto B, Topal OY, Mori F, Atanaskovic Markovic M, Gomes E. Kuyucu S, et al. Pediatr Allergy Immunol. 2025 Jul;36(7):e70103. doi: 10.1111/pai.70103. Pediatr Allergy Immunol. 2025. PMID: 40589376 Free PMC article. Review.

Cite

199

Cite

Artificial Intelligence for Drug-Induced Liver Injury Prediction: A Systematic Review.

Kantagba YMK, Barro SG, Nikiema SLW, Staccini P. Kantagba YMK, et al. Stud Health Technol Inform. 2025 Jun 26;328:183-187. doi: 10.3233/SHTI250698. Stud Health Technol Inform. 2025. PMID: 40588906

Cite

200

Cite

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse events.

Derenzini E, Gibb A, Kwiatek M, Strati P. Derenzini E, et al. Leuk Lymphoma. 2025 Nov;66(11):1990-2002. doi: 10.1080/10428194.2025.2520440. Epub 2025 Jun 30. Leuk Lymphoma. 2025. PMID: 40588166 Free article. Review.

Cite